A retrospective cohort study assessing the effectiveness and safety of combining Vedolizumab and Ustekinumab in Crohn's Disease patients
Latest Information Update: 21 Dec 2020
At a glance
- Drugs Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 21 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020